CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?

Shahbaz, Omar, Mahajan, Sandeep, Lewis, James H.·2017·Expert Opinion on Drug Metabolism & Toxicology
DOI 10.1080/17425255.2017.1362391
Open this paper in CoChat — free account

Abstract

Introduction Over 1500 papers on drug-induced liver injury (DILI) and herb-induced liver injury (HILI) were published in 2016, many of which have the potential to impact clinical practice. Areas covered: Clinical studies and case series that lent themselves to new concepts in diagnosing, and treating DILI were selected for inclusion. Epidemiology of DILI in large prospective registries was highlighted. Causality assessment of drug hepatotoxicity remains challenging, as seen with cases of OxyELITE Pro (OEP). In 2016 updates to the Roussel Uclaf Causality Assessment Method (RUCAM) were published to aid in the accuracy of diagnosing DILI/HILI. New reports of established hepatotoxins were again discussed in 2016, including genetic risk factors for DILI with respect to antituberculous agents. Expert opinion: 2016 marked a turning point in how much credence should be placed in the current causality assessment for DILI/HILI cases. Many recognized hepatotoxins are backed by a relatively few number of literature reports. Danan and Teschke make a strong case that an updated RUCAM should remain the gold standard for diagnosing DILI/HILI going forward, although the role of expert opinion is often still needed in cases where RUCAM falls short. The field of chemoinformatics continues to evolve while we await a truly predictive and diagnostic DILI biomarker.

Overview

Integrity signals

Registry

Crossref · 10.1080/17425255.2017.1362391

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 95

  1. 10.1053/j.gastro.2015.03.006 · DOI · Paper page
  2. 10.3390/ijms17030313 · DOI
  3. 10.1155/2016/2816056 · DOI
  4. 10.1016/j.jep.2014.11.027 · DOI
  5. 10.1517/14740338.2013.774371 · DOI
  6. Teschke R, 2015, J Liver Clin Res, 2, 1013
  7. 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  8. 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  9. Clarke JI, 2016, Expert Opin Drug Saf, 15, 625, 10.1517/14740338.2016.1160057 · DOI · Paper page
  10. 10.3390/ijms17010014 · DOI · Paper page
  11. Fredj NB, 2016, Pharmacogenomics J
  12. 10.2147/DDDT.S87131 · DOI
  13. 10.1089/gtmb.2016.0060 · DOI
  14. 10.1002/hep.28945 · DOI
  15. Zimmerman HJ, 1999, Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver
  16. 10.1007/s40264-016-0423-z · DOI
  17. 10.3390/ijms17020224 · DOI · Paper page
  18. 10.1053/j.gastro.2008.09.011 · DOI · Paper page
  19. 10.1002/hep.28323 · DOI · Paper page
  20. 10.1007/s10620-016-4181-7 · DOI
  21. 10.3390/ijms17040476 · DOI · Paper page
  22. Teschke R, 2016, Ann Hepatology, 15, 1, 10.5604/16652681.1184237 · DOI · Paper page
  23. 10.1097/MCG.0000000000000568 · DOI
  24. 10.1007/s10620-016-4121-6 · DOI
  25. 10.1016/0016-5085(89)91633-8 · DOI
  26. 10.1111/liv.13032 · DOI
  27. 10.1002/hep.28403 · DOI
  28. 10.1002/hep.26709 · DOI · Paper page
  29. 10.1080/17425255.2016.1211110 · DOI
  30. 10.1016/j.cgh.2016.05.043 · DOI · Paper page
  31. 10.1002/hep.23584 · DOI · Paper page
  32. 10.1016/j.gastro.2005.05.006 · DOI · Paper page
  33. 10.1097/FPC.0000000000000230 · DOI · Paper page
  34. 10.1016/S0140-6736(89)91225-7 · DOI
  35. 10.5489/cuaj.1753 · DOI
  36. 10.1111/liv.12899 · DOI
  37. 10.1111/bcp.12565 · DOI
  38. 10.3390/ijms17010114 · DOI
  39. 10.3390/ijms17020235 · DOI
  40. 10.3390/ijms17040580 · DOI
  41. 10.1111/jgh.13323 · DOI · Paper page
  42. 10.1038/ajg.2015.283 · DOI
  43. 10.1016/j.jhep.2016.05.003 · DOI · Paper page
  44. 10.4254/wjh.v8.i20.858 · DOI
  45. 10.1007/s10620-014-3422-x · DOI
  46. 10.1016/j.jhep.2015.07.041 · DOI
  47. 10.1016/j.cgh.2016.06.009 · DOI
  48. 10.1016/j.jhep.2015.11.034 · DOI
  49. 10.1016/j.jhep.2016.01.007 · DOI · Paper page
  50. 10.1002/hep.28926 · DOI
  51. Chu CM, 1998, J Clin Microbiol, 36, 2084, 10.1128/JCM.36.7.2084-2086.1998 · DOI
  52. Sulkowski MS, 2016, Clin Infect Dis, 63, 1202, 10.1093/cid/ciw507 · DOI
  53. 10.1016/j.jcv.2016.02.026 · DOI
  54. 10.1093/cid/civ474 · DOI
  55. 10.1186/s13256-015-0630-8 · DOI
  56. 10.1111/hepr.12578 · DOI
  57. 10.1038/ajg.2016.422 · DOI
  58. 10.7326/M17-0377 · DOI
  59. Bini EJ, 2010, Hepatology, 51, 759, 10.1002/hep.23461 · DOI
  60. Liu CH, 2017, InOpen Forum Infectious Diseases, 4, ofx028, 10.1093/ofid/ofx028 · DOI
  61. 10.1111/liv.13308 · DOI · Paper page
  62. 10.1371/journal.pone.0151587 · DOI
  63. El Bouazzi O, 2016, Pan Afr Med J
  64. 10.1002/pds.3988 · DOI
  65. 10.1371/journal.pone.0157725 · DOI
  66. 10.1007/s12072-008-9085-y · DOI
  67. 10.1007/s11033-012-2433-y · DOI
  68. 10.1164/rccm.2108091 · DOI
  69. 10.5588/ijtld.15.0310 · DOI
  70. 10.1038/hgv.2016.14 · DOI
  71. 10.1038/jhg.2016.10 · DOI
  72. 10.3390/ijerph13080776 · DOI
  73. 10.1016/j.tube.2016.07.006 · DOI
  74. 10.1186/s12864-016-3078-3 · DOI
  75. 10.1038/ajg.2016.349 · DOI
  76. 10.1016/j.cgh.2016.09.007 · DOI
  77. Alonso EM, 2015, J Pediatr Gastroenterol Nutr, 61, 102, 10.1097/MPG.0000000000000814 · DOI
  78. 10.3390/ijms18040803 · DOI
  79. 10.1111/liv.13312 · DOI
  80. 10.1111/liv.13174 · DOI
  81. 10.1002/hep.28678 · DOI
  82. 10.1021/acs.chemrestox.7b00025 · DOI
  83. 10.4254/wjh.v9.i1.30 · DOI
  84. Shi Q, 2016, Ann Clin Lab Sci, 46, 266
  85. Teschke R, 2016, Eur J Pharmaceut Med Res, 3, 154
  86. 10.1002/cld.365 · DOI
  87. 10.1053/j.gastro.2016.10.010 · DOI
  88. 10.1080/17425255.2017.1252749 · DOI
  89. 10.1111/apt.12324 · DOI
  90. Nguyen D, 2014, Adv Pharmacoepidemiol Drug Saf, 3, 1052
  91. 10.2165/00002018-200831030-00007 · DOI
  92. 10.3346/jkms.2016.31.10.1604 · DOI
  93. Teschke R, 2016, Drug, herb, and dietary supplement hepatotoxicity, 10.3390/ijms17091488 · DOI · Paper page
  94. 10.3390/ijms17020201 · DOI
  95. 10.1111/liv.12540 · DOI

Cited by

Sorted by citations

Metadata

Authors
Shahbaz, O., Mahajan, S., & Lewis, J. H.
Affiliations
Department of Medicine, Division of Gastroenterology, Hepatology Section, Georgetown University Hospital, Washington, DC, USA
Venue
Expert Opinion on Drug Metabolism & Toxicology
Publisher
Informa UK Limited
Published
2017-08-28
Volume
13
Issue
9
Pages
935-951
ISSN
  • 1742-5255
  • 1744-7607
DOI
10.1080/17425255.2017.1362391
Cited by
30
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review